Bellisa F. Barbosa-De Freitas Barbosa
Uberlandia, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Anti-Toxoplasma gondii activity of two novel synthetic compounds based on pyridine, benzimidazole and benzoxazole scaffolds in human maternal-fetal interface models.
Journal: Microbial pathogenesis
Published: April 14, 2026
Prenylated chalcone analog-mediated Inhibition of Toxoplasma gondii growth in human trophoblast cell line and villous explants.
Journal: Scientific reports
Published: November 07, 2024
Brazilian red propolis reduces the adhesion of oral biofilm cells and the Toxoplasma gondii intracellular proliferation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 25, 2024
Copaifera spp. oleoresins control Trypanosoma cruzi infection in human trophoblast cells (BeWo) and placental explants.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 11, 2024
Polyalthic acid and oleoresin from Copaifera trapezifolia Hayne reduce Toxoplasma gondii growth in human villous explants, even triggering an anti-inflammatory profile.
Journal: Experimental parasitology
Published: January 18, 2023
BjussuLAAO-II, an l-amino acid oxidase from Bothrops jararacussu snake venom, impairs Toxoplasma gondii infection in human trophoblast cells and villous explants from the third trimester of pregnancy.
Journal: Microbes and infection
Published: November 09, 2022
LPS-mediated activation of TLR4 controls Toxoplasma gondii growth in human trophoblast cell (BeWo) and human villous explants in a dependent-manner of TRIF, MyD88, NF-κB and cytokines.
Journal: Tissue & cell
Published: April 12, 2022
Cyclooxygenase (COX)-2 modulates Toxoplasma gondii infection, immune response and lipid droplets formation in human trophoblast cells and villous explants.
Journal: Scientific reports
Published: March 02, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026